G Medical Innovations Holdings Ltd

As of June 30, 2020, G Medical Innovations Holdings Ltd carries a market capitalization of 23.32M, placing it among publicly traded companies globally. Its enterprise value stands at 32.97M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

G Medical Innovations Holdings Ltd's next confirmed earnings release is scheduled for March 1, 2027.

As of June 30, 2020, G Medical Innovations Holdings Ltd has 3.80M shares outstanding.

These figures are as of June 30, 2020.

As of June 30, 2020, G Medical Innovations Holdings Ltd maintains a current ratio of 0.26, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities.

As of June 30, 2020, G Medical Innovations Holdings Ltd holds 543,000.00 in cash and equivalents against 6.77M in total debt, resulting in a net debt position of 6.23M. Total book value stands at -6.77M, with working capital of -7.08M providing operational flexibility.

These figures cover the twelve months ended June 30, 2020. Total shareholder yield is negative at -19.80, meaning G Medical Innovations Holdings Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

G Medical Innovations Holdings Ltd's most recent stock split took place on November 21, 2022 with a 35:1 split ratio.